Sample 24

Evaluation Instructions

Important: Models were tasked with extracting evidence from documents. Some outputs may be low quality and should be scored accordingly.

Your task: Compare the model-generated prediction (right panel) against the ground truth criteria (left panel).

Clean view: Shows formatted, readable text for easy comparison
Diff view: Highlights differences between ground truth and prediction
Raw view: Shows original unformatted text as it appears in the dataset

Evaluation scale (0-4):

0 = No match: Prediction is unrelated or contradicts the target criteria
1 = Poor match: Minimal overlap with ground truth, major errors or omissions
2 = Partial match: Some key elements captured, but notable gaps or inaccuracies
3 = Good match: Most elements correct, minor differences or formatting issues
4 = Excellent match: Essentially identical content, fully correct capture

Consider both content accuracy and completeness. Some predictions may be technically "correct" but incomplete or out of order.

Ground Truth

INCLUSION CRITERIA

  1. Cohorts 1 and 2: chronic genotype 1 or 3 HCV infection
  2. Cohort 3: chronic genotype 1 or 4 HCV infectionHCV RNA ≥ 10^4 IU/mL at screening
  3. Screening labs within defined thresholds
  4. Cirrhosis determination at screening

EXCLUSION CRITERIA

  1. Females who are pregnant or nursing or males who have a pregnant partner
  2. Prior null response to PEG+RBV therapy
  3. Current of prior history of hepatic decompensation
  4. Infection with hepatitis B virus (HBV) or HIVHistory of clinically significant illness (including psychiatric or cardiac) or any other medical disorder that may interfere with individual's treatment and/or adherence to the protocol
  5. Note: Other protocol defined Inclusion/

EXCLUSION CRITERIA

  1. may apply.

Prediction

Amended Eligibility Criteria (Version 27)

INCLUSION CRITERIA

  1. Adults (≥18 years) with chronic genotype 1 or 3 HCV infection.
  2. Evidence of renal insufficiency (e.g., creatinine clearance < 60 mL/min).

EXCLUSION CRITERIA

  1. Females who are pregnant or nursing or males who have a pregnant partner.
  2. Prior null response to PEG+RBV therapy.
  3. Current or prior history of hepatic decompensation.
  4. Infection with hepatitis B virus (HBV) or HIV.
  5. History of clinically significant illness (including psychiatric or cardiac) or any other medical disorder that may interfere with subject treatment and/or adherence to the protocol.
  6. Changes Made:
  7. Specificity: The

INCLUSION CRITERIA

  1. now explicitly state the requirement for evidence of renal insufficiency.
  2. Conciseness:** The wording has been streamlined for clarity and conciseness.
  3. Let me know if you have any other clinical trial eligibility criteria you'd like me to review!